Effects of the application of lymphatic neuromuscular taping technique in women with primary dysmenorrhea versus short-wave

Not Applicable

Completed

• Conditions: dysmenorrhea; Physical Medicine / Rehabilitation - Physiotherapy; Renal and Urogenital - Pelvic inflammatory disease

• Registration Number: ACTRN12620000395932
• Lead Sponsor: Elena Sanchez Jimenez

Brief Summary

In the experimental group there are statistically significant differences in the abdominal pain in the post-intervention and 24 hours missing these effects shown in the following menstruation and in the lumbo-sacral pain, in the right sacroiliac pain, left and fifth lumbar vertebra pain after the intervention at 20 minutes. It is observed that with the exception of swollen chest and gastric disorders all symptoms increase the duration in the month following the intervention in the control group. In the experimental group, the duration of symptoms does not vary, with the exception of gastric disorders and swollen chest but without statistically significant intragroup differences . There are no intergroup differences in any of the variables studied at each moment of measurement except for the frequency in gastric disorders at the beginning, the experimental group having fewer days of symptomatology and significance in the irritability variable when comparing the two groups the month following the intervention improving the experimental group. Our study has limitations; We have not evaluated the effects obtained after a longer period of time, as well as the short, medium or long-term follow-up, so these actions could be carried out in future investigations. We have only evaluated the effects of a single technique, and not the effect of a comprehensive treatment.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2015-07-31
• Study Start: 2020-03-23
• Last Update Posted: 30 March 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 20

Inclusion Criteria

To participate in this study, the following inclusion criteria were required: female patients, aged between 18-45 years, with a diagnosis of primary dysmenorrhea on the first day of menstruation who had not received manual treatment in the last month, to not interfere with the results, and sign an informed consent document

Exclusion Criteria

The following subjects were excluded: patients who presented secondary dysmenorrhea, gynecological interventions, intrauterine device and contraindication to the use of Kinesiotaping and / or the shortwave.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pressure pain threshold<br>An algometer (Baseline Dolorimeter, Baseline, USA) was used to assess the pain threshold for pressure at the joint point chosen in the study (sacro-iliac and spiny L5).[Immediately after application, 20 minutes after the intervention, 24 hours after the intervention and the following month coinciding with the first day of menstruation];Pain intensity.<br>To assess the intensity of pain in the lumbo-sacral spine and in the abdominal region, we use the Visual Analog Scale (VAS). To do this, patients are shown a horizontal line of 100 mm in length, with numbers from 0 to 10, which indicates to patients that 0 means lack of pain and 10 means unbearable pain.[Immediately after application, 20 minutes after the intervention, 24 hours after the intervention and the following month coinciding with the first day of menstruation]

Secondary Outcome Measures

Name	Time	Method
Menstrual Pain Questionnaire. It,s a composite secundary outcome.<br>The questionnaire includes information on the following points: socio-demographic data (age, profession, level of education); factors that can influence menstrual pain (number of children, years since the first menstruation); characterization of menstrual pain (intensity and location of pain, number of painful periods, time of onset of pain); request for professional help because of menstrual pain; symptoms associated with menstrual pain; strategies used to relieve pain (medication and rest); other symptoms and disorders[Immediately after application, 20 minutes after the intervention, 24 hours after the intervention and the following month coinciding with the first day of menstruation]